Nanobiotix (NBTX) Total Non-Current Liabilities: 2019-2025

  • Nanobiotix's Total Non-Current Liabilities rose 3.39% to $57.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $57.8 million, marking a year-over-year increase of 3.39%. This contributed to the annual value of $79.3 million for FY2024, which is 59.79% up from last year.
  • Nanobiotix's Total Non-Current Liabilities amounted to $57.8 million in Q2 2025, which was down 27.05% from $79.3 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Total Non-Current Liabilities registered a high of $79.3 million during Q4 2024, and its lowest value of $38.7 million during Q2 2022.
  • For the 3-year period, Nanobiotix's Total Non-Current Liabilities averaged around $58.1 million, with its median value being $55.9 million (2024).
  • Per our database at Business Quant, Nanobiotix's Total Non-Current Liabilities dropped by 27.73% in 2022 and then spiked by 60.64% in 2024.
  • Over the past 5 years, Nanobiotix's Total Non-Current Liabilities (Quarterly) stood at $43.6 million in 2021, then fell by 27.73% to $38.7 million in 2022, then climbed by 24.81% to $49.3 million in 2023, then spiked by 60.64% to $79.3 million in 2024, then climbed by 3.39% to $57.8 million in 2025.
  • Its last three reported values are $57.8 million in Q2 2025, $79.3 million for Q4 2024, and $55.9 million during Q2 2024.